The identification of the downstream signals of HK2 demonstrated that the high expression of hub genes, including ITGB2, CD53, C3AR1, CYBB and ITGAM, maybe a potential target for the treatment of glioma. This evidence concerns the gene ITGB2 and central nervous system cancer.